共 83 条
- [1] Lovell R(2012)Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis Clin Gastroenterol Hepatol 10 712-721
- [2] Ford A(2006)The functional gastrointestinal disorders and the Rome III process Gastroenterol 130 1377-1390
- [3] Drossman D(2009)An evidence-based position statement on the management of irritable bowel syndrome Am J Gastroenterol 104 1-35
- [4] Brandt L(2013)Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study Gastroenterology 145 329-338
- [5] Chey W(1998)Quality of life in persons with irritable bowel syndrome: development and validation of a new measure Dig Dis Sci 43 400-411
- [6] Foxx-Orenstein A(2000)Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire Am J Gastroenterol 95 999-1007
- [7] Dove L(1992)Functional bowel disorders and functional abdominal pain Gastroenterol Int 5 75-91
- [8] Lembo A(2007)Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment Am J Gastroenterol 102 1442-1453
- [9] Randall C(1997)The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress Aliment Pharmacol Ther 11 395-402
- [10] Fogel R(1937)The Bi-factor method Psychometrika 2 41-54